SCHEMBL3676400

SCHEMBL3676400

POC(Cc1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.44
SLC6A4 P31645 3/20 0.44
SLC6A3 Q01959 3/20 0.44
EPHX1 P07099 2/20 0.43
SIGMAR1 Q99720 3/20 0.41
ACP3 P15309 1/20 0.41
TAAR1 Q96RJ0 4/20 0.40
MAOA P21397 1/20 0.40
CYP2A6 P11509 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL971331 0.82 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL3950653 0.79 IDO1 (0.47) SLC6A2SLC6A4SLC6A3SIGMAR1ACP3
SCHEMBL10839778 0.78 SRR (0.46) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL6151732 0.78 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL7800334 0.78 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL1520793 0.78 IDO1 (0.50) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL4056401 0.78 SIGMAR1 (0.46) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL675684 0.78 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL6566061 0.77 SLC6A4 (0.53) SLC6A2SLC6A4SLC6A3KCNH2CACNA1C
SCHEMBL6827771 0.77 ACP3 (0.44) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12484369-B2 Composite material and quantum dot light emitting diode TCL TECHNOLOGY GROUP CORPORATION (CN) 2025-11-25 US claimed
CN-119930491-A Synthesis method of polysubstituted pyrrolidone 北京化工大学 2025-05-06 CN claimed
CN-119841777-A Synthesis method and application of C2-substituted dihydroquinoline derivative 南京林业大学 2025-04-18 CN claimed
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2024-09-26 US claimed
CN-114405542-B Supported magnetic nano metal catalyst and preparation method and application thereof 万华化学集团股份有限公司 2024-02-27 CN claimed
EP-4318701-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP claimed
CN-117321818-A Secondary battery and electricity utilization device comprising same 宁德时代新能源科技股份有限公司 2023-12-29 CN claimed
CN-111320526-B Method for preparing hexafluorobutadiene 浙江蓝天环保高科技股份有限公司 2023-09-05 CN claimed
WO-2023102793-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS COMPRISING SAME 宁德时代新能源科技股份有限公司 2023-06-15 WO claimed
CN-116237083-A Catalyst and method for synthesizing imine by catalyzing oxidative coupling of organic primary amine 中国科学院大连化学物理研究所 2023-06-09 CN claimed
CN-110359097-B Method for obtaining On-DNA aromatic hydrocarbon compound through Suzuki coupling reaction in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-09-20 CN claimed
CN-110331447-B Method for preparing On-DNA aryl alkyne compound in construction of DNA coding compound library 上海药明康德新药开发有限公司 2022-05-27 CN claimed
CN-110079867-B On-DNA wittig reaction method in DNA coding compound library and prepared On-DNA olefin compound 上海药明康德新药开发有限公司 2022-01-04 CN claimed
CN-113631564-A Method for producing oligonucleotide having phosphorothioate moiety 味之素株式会社 2021-11-09 CN claimed
US-20210020858-A1 COMPOSITE MATERIAL AND QUANTUM DOT LIGHT EMITTING DIODE TCL TECHNOLOGY GROUP CORPORATION (CN) 2021-01-21 US claimed
US-20210020838-A1 COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND QUANTUM DOT LIGHT-EMITTING DIODE TCL TECHNOLOGY GROUP CORPORATION (CN) 2021-01-21 US claimed
CN-111518145-A Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof 荆楚理工学院 2020-08-11 CN claimed
CN-111320526-A Method for preparing hexafluorobutadiene 浙江蓝天环保高科技股份有限公司 2020-06-23 CN claimed
CN-122059866-A Method for synthesizing amide by using visible light induced amine and carbon dioxide 南京理工大学 2026-05-19 CN disclosed
US-3941847-A POLYBUTADIENE BRIDGESTONE TIRE COMPANY LIMITED (JA) 1976-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240322260-A1 SECONDARY BATTERY AND ELECTRICAL APPARATUS CONTAINING THE SAME SOD1, SOD3, CAT SLC6A2 1191/4885SLC6A4 3575/4885SLC6A3 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.